This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Comparison of Bowel Cleansing Regimens Prior to Colonoscopy (PRECOL2011-1)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute, Naples
ClinicalTrials.gov Identifier:
NCT01649674
First received: July 23, 2012
Last updated: March 28, 2017
Last verified: March 2017
July 23, 2012
March 28, 2017
November 2011
July 2017   (Final data collection date for primary outcome measure)
  • Boston Bowel Preparation Scale value [ Time Frame: at time of colonscopy ]
    evaluated by two endoscopists who are blinded to treatment assigned at randomization
  • patient reported acceptability score [ Time Frame: just prior to colonscopy ]
    using visual analog scale
Same as current
Complete list of historical versions of study NCT01649674 on ClinicalTrials.gov Archive Site
percent of bowel cleansing regimen dose assumed as reported by patient [ Time Frame: just prior to colonoscopy ]
Same as current
Not Provided
Not Provided
 
Comparison of Bowel Cleansing Regimens Prior to Colonoscopy
PRECOL2011-1: Sodium Picophosphate and Magnesium Citrate Versus Polyethylene Glycol as Evacuating Treatment Prior to Colonoscopy: Phase IV Randomized Trial.
The purpose of this study is to to compare two bowel preparation regimens of patients who will undergo colonoscopy, in terms of quality of bowel preparation and in terms of patient satisfaction.
Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: No masking
Primary Purpose: Treatment
Patients Undergoing Elective Colonoscopy
  • Drug: polyethylene glycole (PEG) solution
  • Drug: sodium picosulphate and magnesium citrate solution
  • Active Comparator: PEG
    polyethylene glycol solution 2 liters
    Intervention: Drug: polyethylene glycole (PEG) solution
  • Active Comparator: NapP
    Sodium picosulphate and magnesium citrate solution 300 ml
    Intervention: Drug: sodium picosulphate and magnesium citrate solution
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
525
December 2017
July 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

• Subjects who are candidate to undergo colonoscopy: Diagnosis Screening Follow-up after previous polypectomy

  • Informed consent
  • Age > 18 years

Exclusion Criteria:

  • Previous colonic resection
  • Severe inflammatory bowel disease (IBD)
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Italy
 
 
NCT01649674
PRECOL2011-1
2011-000587-10 ( Registry Identifier: EudraCT )
No
Not Provided
Not Provided
National Cancer Institute, Naples
National Cancer Institute, Naples
Not Provided
Principal Investigator: Valentina D'Angelo, M.D. National Cancer Institute, Naples
Principal Investigator: Mario de Bellis, M.D. National Cancer Institute, Naples
National Cancer Institute, Naples
March 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP